Ulrich Karl Walter Spengler

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998.

Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.